Does the Diffusion Profile Differ Between Botulinum Toxin Type a Formulations? Implications for the Management of Post-Stroke Spasticity

Botulinum toxin type A is a first-line treatment for post-stroke spasticity, with selective action at nerve endings and minimal effects beyond the injection site. However, concerns about potential adverse reactions due to toxin diffusion and spread can significantly influence physicians’ therapeutic...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Alessandro Picelli, Stefano Tamburin, Rita Di Censo, Nicola Smania, Mirko Filippetti
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2024-11-01
Edice:	Toxins
Témata:	botulinum toxins muscle spasticity therapeutics
On-line přístup:	https://www.mdpi.com/2072-6651/16/11/480
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!